Evidence map›Paper›PMID 24464527›Full record

ReviewPsychopharmacology2014

Reducing substance use during adolescence: a translational framework for prevention.

Jessica J Stanis, Susan L Andersen

Abstract readReview
In one paragraph

Review in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Brief Underage Alcohol Use Screener Scores Predict Health Risk Behaviors.The Journal of school nursing : the official publication of the National Association of School Nurses · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jessica J StanisLaboratory of Developmental Neuropharmacology, McLean Hospital and Department of Psychiatry, Harvard Medical School, Mailstop 333, 115 Mill Street, Belmont, MA, 02478, USA.
Susan L Andersen
Harvard University · US

Funding

Early Drug Exposure and Drug Reward MechanismsR01DA015403 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI ANDERSEN, SUSAN L · 2003 to 2014
$2.6M
Developmental Mechanisms Underlying Risk Behaviors and Their TreatmentR01MH091114 · NIMH · MCLEAN HOSPITAL · PI ANDERSEN, SUSAN L, SONNTAG, KAI CHRISTIAN · 2011 to 2015
$1.8M
Sensitive periods, development, and substance abuseR01DA026485 · NIDA · MCLEAN HOSPITAL · PI ANDERSEN, SUSAN L · 2011 to 2015
$1.8M
NIDA NIH HHS DA-026485NIDA NIH HHS R01 DA015403NIDA NIH HHS R01 DA026485NIDA NIH HHS R01 DA15403NIMH NIH HHS MH-091114NIMH NIH HHS R01 MH091114
6 · The paper itself

Abstract

rationaleMost substance use is initiated during adolescence when substantial development of relevant brain circuitry is still rapidly maturing. Developmental differences in reward processing, behavioral flexibility, and self-regulation lead to changes in resilience or vulnerability to drugs of abuse depending on exposure to risk factors. Intervention and prevention approaches to reducing addiction in teens may be able to capitalize on malleable brain systems in a predictable manner.

objectiveThis review will highlight what is known about how factors that increase vulnerability to addiction, including developmental stage, exposure to early life adversity (ranging from abuse, neglect, and bullying), drug exposure, and genetic predisposition, impact the development of relevant systems. RESULTS AND

conclusionsAppropriate, early intervention may restore the normal course of an abnormal trajectory and reduce the likelihood of developing a substance use disorder (SUD) later in life. A considerable amount is known about the functional neuroanatomy and/or pharmacology of risky behaviors based on clinical and preclinical studies, but relatively little has been directly translated to reduce their impact on addiction in high-risk children or teenagers. An opportunity exists to effectively intervene before adolescence when substance use is likely to emerge.

Indexed as

AdolescentAdolescent DevelopmentAnimalsBrainHumansSubstance-Related Disorders

Identifiers

PMID24464527
PMCPMC3969413
OpenAlexW2071258843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.